At end of June, the Federal Ministry of Research, Technology, and Space (BMFTR) announced its funding program “e2Health – In Silico Research for the Medicine of the Future.” It supports the development and further advancement of in silico methods, software tools, as well as AI technologies for health research.

An international research team at the Center for Photon Research at Paul Scherrer Institute (PSI), led by Dr. Goran Lovric, has succeeded in virtually staining tissue samples using high-resolution micro-computed tomography (µCT) and artificial intelligence. This provides results similar to those of conventional histology methods used in medical diagnostics and research, in which tissue is first cut into extremely thin sections and then stained, for example, to highlight organelles or cells in order to study tissue changes.

The Innovative Health Initiative (IHI) has announced its 13th call for proposals. It aims to support innovators in the healthcare sector in reducing the use of animals in drug safety studies and combating diseases related to aging and the immune system.

Researchers at the RCSI University of Medicine and Health Sciences in Dublin, Ireland, have developed an artificial model of the mitral valve that faithfully replicates the valve’s complex mechanical behavior in the human heart. The study could help researchers better understand heart valve diseases and develop new treatment approaches.